Wong-Brown MW - Search Results

1

Methyl-Donor and Cofactor Nutrient Intakes in the First 2-3 Years and Global DNA Methylation at Age 4: A Prospective Cohort Study.

Taylor RM, Smith R, Collins CE, Mossman D, Wong-Brown MW, Chan EC, Evans TJ, Attia JR, Smith T, Butler T, Hure AJ. Taylor RM, et al. Among authors: wong brown mw. Nutrients. 2018 Feb 27;10(3):273. doi: 10.3390/nu10030273. Nutrients. 2018. PMID: 29495543 Free PMC article.

2

Global DNA methylation and cognitive and behavioral outcomes at 4 years of age: A cross-sectional study.

Taylor RM, Smith R, Collins CE, Mossman D, Wong-Brown MW, Chan EC, Evans TJ, Attia JR, Buckley N, Drysdale K, Smith T, Butler T, Hure AJ. Taylor RM, et al. Among authors: wong brown mw. Brain Behav. 2020 Apr;10(4):e01579. doi: 10.1002/brb3.1579. Epub 2020 Feb 28. Brain Behav. 2020. PMID: 32109009 Free PMC article.

3

Targeting DNA Repair in Ovarian Cancer Treatment Resistance.

Wong-Brown MW, van der Westhuizen A, Bowden NA. Wong-Brown MW, et al. Clin Oncol (R Coll Radiol). 2020 Aug;32(8):518-526. doi: 10.1016/j.clon.2020.03.005. Epub 2020 Apr 3. Clin Oncol (R Coll Radiol). 2020. PMID: 32253106 Review.

4

DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients.

Mathe A, Wong-Brown M, Locke WJ, Stirzaker C, Braye SG, Forbes JF, Clark SJ, Avery-Kiejda KA, Scott RJ. Mathe A, et al. Sci Rep. 2016 Sep 27;6:33435. doi: 10.1038/srep33435. Sci Rep. 2016. PMID: 27671774 Free PMC article.

5

Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy.

Wong-Brown MW, van der Westhuizen A, Bowden NA. Wong-Brown MW, et al. BMC Cancer. 2022 Jan 24;22(1):100. doi: 10.1186/s12885-022-09197-w. BMC Cancer. 2022. PMID: 35073851 Free PMC article.

6

BCL-2 family isoforms in apoptosis and cancer.

Warren CFA, Wong-Brown MW, Bowden NA. Warren CFA, et al. Among authors: wong brown mw. Cell Death Dis. 2019 Feb 21;10(3):177. doi: 10.1038/s41419-019-1407-6. Cell Death Dis. 2019. PMID: 30792387 Free PMC article. Review.

7

The presence of the intron 3 16 bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low Δ40p53:p53 ratio and better outcome.

Morten BC, Wong-Brown MW, Scott RJ, Avery-Kiejda KA. Morten BC, et al. Carcinogenesis. 2016 Jan;37(1):81-86. doi: 10.1093/carcin/bgv164. Epub 2015 Nov 19. Carcinogenesis. 2016. PMID: 26586794

8

Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer.

Matthews BG, Bowden NA, Wong-Brown MW. Matthews BG, et al. Among authors: wong brown mw. Cancers (Basel). 2021 Nov 29;13(23):5993. doi: 10.3390/cancers13235993. Cancers (Basel). 2021. PMID: 34885103 Free PMC article. Review.

9

Novel genes associated with lymph node metastasis in triple negative breast cancer.

Mathe A, Wong-Brown M, Morten B, Forbes JF, Braye SG, Avery-Kiejda KA, Scott RJ. Mathe A, et al. Sci Rep. 2015 Nov 5;5:15832. doi: 10.1038/srep15832. Sci Rep. 2015. PMID: 26537449 Free PMC article.

10

Low prevalence of germline PALB2 mutations in Australian triple-negative breast cancer.

Wong-Brown MW, Avery-Kiejda KA, Bowden NA, Scott RJ. Wong-Brown MW, et al. Int J Cancer. 2014 Jan 15;134(2):301-5. doi: 10.1002/ijc.28361. Epub 2013 Sep 23. Int J Cancer. 2014. PMID: 23824750 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page